Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 Inspire Medical Systems, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdi ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q3 2021 Earnings Conference Call November 2, 2021 5:00 PM ET Company Participants Megan Rowekamp - Director of Financial Reporting Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Jon Block - Stifel Danielle Antalffy - SVB Leerink Chris Pasquale - Guggenheim Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Adam Maeder - Piper Sandler Michael Polark - Baird Ravi Misra - Berenberg Capital Sura ...

Table of Contents For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Inspire Medical Systems, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI ...

Sleep Apnea Innovation 1 Inspire Medical Systems, Inc. August 2021 NYSE: INSP Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forwardlooking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' ''pr ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2021 Earnings Conference Call August 3, 2021 5:00 PM ET Company Participants Bob Yedid - MD, LifeSci Advisors, IR Tim Herbert - President and CEO Rick Buchholz - CFO Conference Call Participants Robbie Marcus - JPMorgan Chris Pasquale - Guggenheim Larry Biegelsen - Wells Fargo Brad Bowers - Bank of America Merrill Lynch Richard Newitter - SVB Leerink Michael Polark - Baird Adam Maeder - Piper Sandler Ravi Misra - Berenberg Suraj Kalia - Oppenheimer Operator Greet ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Inspire Med ...

Sleep Apnea Innovation 1 Inspire Medical Systems, Inc. June 2021 NYSE: INSP Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forwardlooking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' ''proj ...

Sleep Apnea Innovation 1 Inspire Medical Systems, Inc. May 2021 NYSE: INSP Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forwardlooking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' ''proje ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2021 Earnings Conference Call May 4, 2021 5:00 PM ET Company Participants Bob Yedid – Investor Relations-LifeSci Advisors Tim Herbert – President and Chief Executive Officer Rick Buchholz – Chief Financial Officer Conference Call Participants Robbie Marcus – J.P. Morgan Jon Block – Stifel Chris Pasquale – Guggenheim Jamie Perse – Goldman Sachs Richard Newitter – SVB Leerink Bradley Bowers – Bank of America Merrill Lynch Adam Maeder – Piper Sandler Lei Huang – Wel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Inspire Me ...